Calendrier des promotions Northwest Biotherapeutics, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. plus de détails| ISIN | US66737P6007 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.nwbio.com |
| Цена ао | 0.53 |
| Changement de prix par jour: | +1.44% (0.27) |
|---|---|
| Changement de prix par semaine: | +5.35% (0.26) |
| Changement de prix par mois: | -2.18% (0.28) |
| Changement de prix sur 3 mois: | -14.41% (0.32) |
| Changement de prix sur six mois: | -34.79% (0.42) |
| Changement de prix par an: | -60.87% (0.7) |
| Evolution du prix sur 3 ans: | -59.72% (0.68) |
| Evolution du prix sur 5 ans: | +21.73% (0.225) |
| Evolution des prix sur 10 ans: | 0% (0.2739) |
| Evolution des prix depuis le début de l'année: | -5.55% (0.29) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| Moloney Securities Asset Management, LLC | 358160 | 0.03 |
| Opus Capital Group, LLC | 60150 | 0.01 |
| Williams Jones Wealth Management, LLC. | 44000 | 0 |
| Lee, Danner & Bass, Inc. | 20000 | 0 |
| MAI Capital Management | 20000 | 0 |
| Advisors Management Group, Inc. | 10270 | 0 |
| Bartlett & Co. | 4292 | 0 |
| Bartlett & Co. Wealth Management LLC | 4292 | 0 |
| Coston, McIsaac & Partners | 1000 | 0 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Ms. Linda F. Powers J.D. | Chairperson, CEO, President, CFO & Chief Accounting Officer | 925k | 1956 (69 années) |
| Dr. Alton L. Boynton Ph.D. | Founder, Chief Scientific Officer, Secretary & Director | 375k | 1945 (80 années) |
| Dr. Marnix L. Bosch M.B.A., Ph.D. | Chief Technical Officer | 453.6k | 1959 (66 années) |
| Mr. Leslie J. Goldman | Senior VP & General Counsel | 725k | 1945 (80 années) |
| Mr. David Innes | Vice President of Investor Relations | N/A |
Adresse: United States, Bethesda. MD, 4800 Montgomery Lane - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.nwbio.com
Site web: https://www.nwbio.com
